Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Careful use of science to advance the debate on the UK Cancer Drugs Fund.

Lakdawalla DN, Jena AB, Doctor JN.

JAMA. 2014 Jan 1;311(1):25-6. doi: 10.1001/jama.2013.282839. No abstract available.

2.

UK Cancer Drugs Fund to reassess 42 agents.

Cagney H.

Lancet Oncol. 2015 Jan;16(1):e8. doi: 10.1016/S1470-2045(14)71137-4. Epub 2014 Nov 21. No abstract available.

PMID:
25638560
3.

Which way now for the Cancer Drugs Fund?

Jack A.

BMJ. 2014 Sep 9;349:g5524. doi: 10.1136/bmj.g5524. No abstract available.

PMID:
25204283
4.

Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity.

Emmerich N.

Br J Hosp Med (Lond). 2015 Apr;76(4):186-7. doi: 10.12968/hmed.2015.76.4.186. No abstract available.

PMID:
25853345
5.

Cancer drugs offer hope, but at huge expense.

Berenson A.

N Y Times Web. 2005 Jul 12:A1, C3. No abstract available.

PMID:
16075470
6.

Expensive cancer drugs with modest benefit ignite debate over solutions.

Sinha G.

J Natl Cancer Inst. 2008 Oct 1;100(19):1347-9. doi: 10.1093/jnci/djn357. Epub 2008 Sep 23. No abstract available.

PMID:
18812543
7.

Being NICE is not the problem!

Jonsson B.

Eur J Cancer. 2009 May;45(7):1100-2. doi: 10.1016/j.ejca.2009.01.035. Epub 2009 Mar 4. No abstract available.

PMID:
19268570
8.

MPs find no evidence that Cancer Drugs Fund was spent wisely.

Hawkes N.

BMJ. 2016 Feb 5;352:i755. doi: 10.1136/bmj.i755. No abstract available.

PMID:
26850036
9.

Five cancer drugs back on NHS list after deals with drug companies.

Hawkes N.

BMJ. 2015 Nov 5;351:h5985. doi: 10.1136/bmj.h5985. No abstract available.

PMID:
26546283
10.

Reforming the cancer drug fund.

Buxton M, Longworth L, Raftery J, Sculpher M, Towse A.

BMJ. 2014 Nov 28;349:g7276. doi: 10.1136/bmj.g7276. No abstract available.

PMID:
25432928
11.

Under pressure: homeopathy UK and its detractors.

Milgrom LR.

Forsch Komplementmed. 2009 Aug;16(4):256-61. doi: 10.1159/000228916. Epub 2009 Jul 30.

PMID:
19729937
12.

Cancer charity demands extension of drug fund despite criticisms it is unfair.

Limb M.

BMJ. 2014 Oct 28;349:g6507. doi: 10.1136/bmj.g6507. No abstract available.

PMID:
25354675
13.

Oncology pharmaceutical funding in New Zealand: a different approach and a proposal.

Beatty PA, Laking GR.

J Oncol Pract. 2015 May;11(3):249-51. doi: 10.1200/JOP.2014.000083. Epub 2015 Mar 31. No abstract available.

PMID:
25829524
14.

Cost to the NHS of Roche oncology treatments.

Sikora K.

J R Soc Med. 2007 Sep;100(9):396-7. No abstract available.

15.

No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog.

Kmietowicz Z.

BMJ. 2015 Sep 16;351:h4988. doi: 10.1136/bmj.h4988. No abstract available.

PMID:
26384368
16.

NHS will not pay for drugs that offer little clinical benefit, says cancer fund boss.

Kmietowicz Z.

BMJ. 2015 Jan 8;350:h125. doi: 10.1136/bmj.h125. No abstract available.

PMID:
25569117
17.

Cost to the NHS of Roche oncology treatments.

Atkins M.

J R Soc Med. 2007 Jul;100(7):303. No abstract available.

18.

A question of health. The lottery of cancer care.

[No authors listed]

Health Serv J. 1997 Dec 18;107(5584):suppl 1-4 following 24. No abstract available.

PMID:
10184833
20.

Key changes to cancer care in the UK.

[No authors listed]

Br J Nurs. 2015 Feb 26-Mar 11;24(4):S3. doi: 10.12968/bjon.2015.24.Sup4.S3. No abstract available.

PMID:
25723370

Supplemental Content

Support Center